ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
ResMed (NYSE: RMD, ASX: RMD) has announced plans to release its financial and operational results for the first quarter of fiscal year 2025. The release is scheduled for Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. This announcement provides investors and analysts with a specific date to anticipate the company's quarterly performance update, which is important for assessing ResMed's financial health and market position in the medical equipment industry.
ResMed (NYSE: RMD, ASX: RMD) ha annunciato l'intenzione di pubblicare i risultati finanziari e operativi per il primo trimestre dell'anno fiscale 2025. La pubblicazione è programmata per giovedì 24 ottobre 2024, dopo la chiusura della Borsa di New York. A seguito della pubblicazione, il management di ResMed ospiterà un webcast per discutere i risultati. Questo annuncio fornisce agli investitori e agli analisti una data specifica per anticipare l'aggiornamento delle performance trimestrali dell'azienda, importante per valutare la salute finanziaria di ResMed e la sua posizione di mercato nell'industria delle attrezzature mediche.
ResMed (NYSE: RMD, ASX: RMD) ha anunciado planes para publicar sus resultados financieros y operativos para el primer trimestre del año fiscal 2025. La publicación está programada para el jueves 24 de octubre de 2024, después del cierre de la Bolsa de Nueva York. Después de la publicación, la administración de ResMed llevará a cabo una transmisión web para discutir los resultados. Este anuncio proporciona a los inversores y analistas una fecha específica para anticipar la actualización del desempeño trimestral de la empresa, lo cual es importante para evaluar la salud financiera y la posición de mercado de ResMed en la industria de equipos médicos.
ResMed (NYSE: RMD, ASX: RMD)는 2025 회계연도 첫 분기 재무 및 운영 결과 발표를 계획하고 있다고 발표했습니다. 발표는 2024년 10월 24일 목요일, 뉴욕 증권 거래소가 마감된 후 진행될 예정입니다. 발표 후 ResMed 경영진은 결과를 논의하기 위한 웹캐스트를 진행할 것입니다. 이번 발표는 투자자와 분석가에게 회사의 분기 성과 업데이트를 기대할 수 있는 구체적인 날짜를 제공하며, 이는 의료 기기 산업에서 ResMed의 재무 건전성과 시장 위치를 평가하는 데 중요합니다.
ResMed (NYSE: RMD, ASX: RMD) a annoncé des projets de publication de ses résultats financiers et opérationnels pour le premier trimestre de l'exercice 2025. La publication est prévue pour le jeudi 24 octobre 2024, après la clôture de la Bourse de New York. Suite à la publication, la direction de ResMed animera un webinaire pour discuter des résultats. Cette annonce fournit aux investisseurs et aux analystes une date spécifique pour anticiper la mise à jour de la performance trimestrielle de l'entreprise, ce qui est important pour évaluer la santé financière et la position de marché de ResMed dans l'industrie des équipements médicaux.
ResMed (NYSE: RMD, ASX: RMD) hat Pläne angekündigt, die finanziellen und betrieblichen Ergebnisse für das erste Quartal des Geschäftsjahres 2025 zu veröffentlichen. Die Veröffentlichung ist für Donnerstag, den 24. Oktober 2024, nach dem Schließen der New Yorker Börse angesetzt. Nach der Veröffentlichung wird das Management von ResMed ein Webcast zur Diskussion der Ergebnisse veranstalten. Diese Ankündigung gibt Investoren und Analysten ein konkretes Datum, um die vierteljährliche Leistungsaktualisierung des Unternehmens zu erwarten, was wichtig ist, um die finanzielle Gesundheit und die Marktposition von ResMed in der Medizintechnikbranche zu bewerten.
- None.
- None.
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| http://investor.resmed.com |
| Thursday, October 24, 2024 |
| 1:30 p.m. PDT / 4:30 p.m. EDT |
| London, Thursday, October 24, 2024, 9:30 p.m. BST Sydney, Friday, October 25, 2024, 7:30 a.m. AEDT |
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 24, 2024, until November 7, 2024, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13749420
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed (RMD) release its Q1 FY2025 earnings?
What will ResMed (RMD) do after releasing its Q1 FY2025 results?
Which stock exchanges is ResMed (RMD) listed on?
What fiscal year period will ResMed's (RMD) upcoming earnings report cover?
